Korro Bio, Inc. Depreciation
Korro Bio, Inc. (KRRO) reported Depreciation of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Korro Bio, Inc. depreciation for the quarter ending 2026-06-30 was $400.00K, a 66.67% decline year-over-year.
- Korro Bio, Inc. depreciation for the quarter ending 2026-03-31 was $380.00K, a 68.98% decline year-over-year.
- Korro Bio, Inc. depreciation for the quarter ending 2025-12-31 was $649.00K, a 48.20% decline year-over-year.
- Korro Bio, Inc. depreciation for the quarter ending 2025-09-30 was $1.20M, a 33.33% increase year-over-year.
- Korro Bio, Inc. depreciation for fiscal 2025 was $4.28M, a 20.06% increase from fiscal 2024.
- Korro Bio, Inc. depreciation for fiscal 2024 was $3.56M, a 1.79% decline from fiscal 2023.
- Korro Bio, Inc. depreciation for fiscal 2023 was $3.63M, a 44.56% increase from fiscal 2022.
- Korro Bio, Inc. depreciation for fiscal 2022 was $2.51M, a 9.51% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-06 | $745.00K 10-Q · filed 2026-08-06 | $1.43M derived: sum of 3 quarters · filed 2026-08-06 | $2.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $380.00K 10-Q · filed 2026-05-07 | $1.03M derived: sum of 2 quarters · filed 2026-05-07 | $2.23M derived: sum of 3 quarters · filed 2026-05-07 | $3.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.85M derived: sum of 2 quarters · filed 2026-03-12 | $3.05M derived: sum of 3 quarters · filed 2026-08-06 | $4.28M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $1.20M 10-Q · filed 2025-11-12 | $2.40M derived: sum of 2 quarters · filed 2026-08-06 | $3.63M 10-Q · filed 2025-11-12 | $4.88M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-06 | $2.45M 10-Q · filed 2026-08-06 | $3.68M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.23M 10-Q · filed 2026-05-07 | $2.48M derived: sum of 2 quarters · filed 2026-05-07 | $3.38M derived: sum of 3 quarters · filed 2026-05-07 | $4.08M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.15M derived: sum of 2 quarters · filed 2026-03-12 | $2.85M derived: sum of 3 quarters · filed 2026-03-12 | $3.56M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $900.00K 10-Q · filed 2025-11-12 | $1.60M derived: sum of 2 quarters · filed 2025-11-12 | $2.31M 10-Q · filed 2025-11-12 | $3.31M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $700.00K 10-Q · filed 2025-08-12 | $1.45M 10-Q · filed 2025-08-12 | $2.41M derived: sum of 3 quarters · filed 2025-08-12 | $2.80M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $726.00K 10-Q · filed 2025-05-07 | $1.71M derived: sum of 2 quarters · filed 2025-05-07 | $2.10M derived: sum of 3 quarters · filed 2025-05-07 | $2.59M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.37M derived: sum of 2 quarters · filed 2025-03-18 | $1.86M derived: sum of 3 quarters · filed 2025-03-18 | $3.63M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $385.00K 10-Q · filed 2023-11-02 | $879.00K derived: sum of 2 quarters · filed 2023-11-02 | $2.65M 10-Q · filed 2024-11-12 | $1.88M 10-Q · filed 2023-11-02 | $2.10M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2023-06-30 | $494.00K 10-Q · filed 2023-08-10 | $1.73M 10-Q · filed 2024-08-13 | $1.49M 10-Q · filed 2023-08-10 | $1.72M derived: sum of 3 quarters · filed 2024-05-14 | $2.40M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2023-03-31 | $809.00K 10-Q · filed 2024-05-14 | $1.00M 10-Q · filed 2023-05-12 | $1.23M derived: sum of 2 quarters · filed 2024-05-14 | $1.91M derived: sum of 3 quarters · filed 2024-05-14 | $2.59M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $1.10M derived: sum of 2 quarters · filed 2024-03-26 | $1.78M derived: sum of 3 quarters · filed 2024-03-26 | $2.51M 10-K · filed 2024-03-26 | $2.77M 10-K · filed 2023-03-10 | |||
| 2022-09-30 | $679.00K 10-Q · filed 2023-11-02 | $1.37M derived: sum of 2 quarters · filed 2023-11-02 | $2.09M 10-Q · filed 2023-11-02 | $2.83M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $689.00K 10-Q · filed 2023-08-10 | $1.42M 10-Q · filed 2023-08-10 | $2.15M derived: sum of 3 quarters · filed 2023-08-10 | $2.89M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $726.00K 10-Q · filed 2023-05-12 | $1.46M derived: sum of 2 quarters · filed 2023-05-12 | $2.20M derived: sum of 3 quarters · filed 2023-05-12 | $3.12M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $1.47M derived: sum of 2 quarters · filed 2023-03-10 | $2.39M derived: sum of 3 quarters · filed 2023-03-10 | $2.77M 10-K · filed 2023-03-10 | ||||
| 2021-09-30 | $735.00K 10-Q · filed 2022-11-08 | $1.66M derived: sum of 2 quarters · filed 2022-11-08 | $2.04M 10-Q · filed 2022-11-08 | $2.42M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $921.00K 10-Q · filed 2022-08-09 | $1.30M 10-Q · filed 2022-08-09 | $1.69M derived: sum of 3 quarters · filed 2022-08-09 | $1.99M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $382.00K 10-Q · filed 2022-05-04 | $768.00K derived: sum of 2 quarters · filed 2022-05-04 | $1.07M derived: sum of 3 quarters · filed 2022-05-04 | $1.31M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $687.00K derived: sum of 2 quarters · filed 2022-03-15 | $931.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.15M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $301.00K 10-Q · filed 2021-11-15 | $545.00K derived: sum of 2 quarters · filed 2021-11-15 | $760.00K 10-Q · filed 2021-11-15 | $985.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $244.00K 10-Q · filed 2021-08-12 | $459.00K 10-Q · filed 2021-08-12 | $684.00K derived: sum of 3 quarters · filed 2021-08-12 | $899.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $215.00K 10-Q · filed 2021-05-13 | $440.00K derived: sum of 2 quarters · filed 2021-05-13 | $655.00K derived: sum of 3 quarters · filed 2021-05-13 | $783.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $440.00K derived: sum of 2 quarters · filed 2021-03-29 | $568.00K derived: sum of 3 quarters · filed 2021-03-29 | $813.00K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $215.00K 10-Q · filed 2020-11-16 | $343.00K derived: sum of 2 quarters · filed 2020-11-16 | $588.00K 10-Q · filed 2020-11-16 | $720.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $128.00K 10-Q · filed 2020-08-12 | $374.00K 10-Q · filed 2020-08-12 | $505.00K derived: sum of 3 quarters · filed 2020-08-12 | $653.00K derived: sum of 4 quarters · filed 2020-08-12 | ||||
| 2019-03-31 | $167.00K 10-Q · filed 2020-05-14 | $377.00K derived: sum of 2 quarters · filed 2020-05-14 | $525.00K derived: sum of 3 quarters · filed 2020-05-14 | |||||
| 2018-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $358.00K derived: sum of 2 quarters · filed 2020-03-26 | $654.00K 10-K · filed 2020-03-26 | |||||
| 2018-09-30 | $148.00K 10-Q · filed 2019-11-18 | $444.00K 10-Q · filed 2019-11-18 | ||||||
| 2017-12-31 | $531.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |